Medios AG/€ILM1

05:30
03:10
00:45
22:25
20:00
1D1W1MYTD1Y5YMAX

About Medios AG

Medios AG, headquartered in Berlin, Germany, specializes in the supply and manufacturing of specialty pharmaceutical products, focusing on treatments for chronic and rare diseases. The company operates through two primary segments: Pharmaceutical Supply, offering a portfolio of approximately 1,000 specialty pharma drugs across therapeutic areas such as oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia; and Patient-Specific Therapies, producing individualized medications, including cytostatic infusions, antibody therapies, virostatic and antibiotic medications, and parenteral nutrition solutions, with around 400,000 preparations completed in fiscal year 2023. Founded in 2016, Medios AG has expanded its geographic footprint to include operations in Germany, the Netherlands, Belgium, and Spain. The company's strategic positioning emphasizes individualized medicine, collaborating with pharmacies, specialist practices, and pharmaceutical companies to make innovative therapies widely accessible.

Ticker

€ILM1

Primary listing

XETRA

Industry

Health Care Providers and Services
Headquarters

Employees

1,037

Medios AG Metrics

BasicAdvanced
€327M
21.53
€0.59
1.20
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €ILM1

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs